Cargando…
Pilot Evaluation of Two Fasciola hepatica Biomarkers for Supporting Triclabendazole (TCBZ) Efficacy Diagnostics
Fasciola hepatica, the causative agent of fasciolosis, is a global threat to public health, animal welfare, agricultural productivity, and food security. In the ongoing absence of a commercial vaccine, independent emergences of anthelmintic-resistant parasite populations worldwide are threatening th...
Autores principales: | Collett, Clare F., Morphew, Russell M., Timson, David, Phillips, Helen C., Brophy, Peter M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435721/ https://www.ncbi.nlm.nih.gov/pubmed/32751696 http://dx.doi.org/10.3390/molecules25153477 |
Ejemplares similares
-
Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica
por: Davis, Chelsea N., et al.
Publicado: (2020) -
The soluble glutathione transferase superfamily: role of Mu class in triclabendazole sulphoxide challenge in Fasciola hepatica
por: Stuart, Rebekah B., et al.
Publicado: (2021) -
Fasciola hepatica Cathepsin
L Zymogens: Immuno-Proteomic Evidence for Highly Immunogenic Zymogen-Specific
Conformational Epitopes to Support Diagnostics Development
por: Collett, Clare F., et al.
Publicado: (2022) -
Apparent Triclabendazole-Resistant Human Fasciola hepatica Infection, the Netherlands
por: Winkelhagen, Annemarie J.S., et al.
Publicado: (2012) -
Confirmation of Fasciola hepatica resistant to triclabendazole in naturally infected Australian beef and dairy cattle()
por: Brockwell, Yvette M., et al.
Publicado: (2013)